Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Abstract

2020): Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease, Journal of Biomolecular Structure and Dynamics, ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in the current COVID-19 pandemic. Worldwide this disease has infected over 2.5 million individuals with a mortality rate ranging from 5 to 10%. There are several efforts going on in the drug discovery to control the SARS-CoV-2 viral infection. The main protease (M Pro ) plays a critical role in viral replication and maturation, thus can serve as the primary drug target. To understand the structural evolution of M Pro , we have performed phylogenetic and Sequence Similarity Network analysis, that depicted divergence of Coronaviridae M Pro in five clusters specific to viral hosts. This clustering was corroborated with the comparison of M Pro structures. Furthermore, it has been observed that backbone and binding site conformations are conserved despite variation in some of the residues. These attributes can be exploited to repurpose available viral protease inhibitors against SARS-CoV-2 M Pro . In agreement with this, we performed screening of $7100 molecules including active ingredients present in the Ayurvedic antitussive medicines, anti-viral phytochemicals and synthetic anti-virals against SARS-CoV-2 M Pro as the primary target. We identified several natural molecules like d-viniferin, myricitrin, taiwanhomoflavone A, lactucopicrin 15-oxalate, nympholide A, afzelin, biorobin, hesperidin and phyllaemblicin B that strongly binds to SARS-CoV-2 M Pro . Intrestingly, these molecules also showed strong binding with other potential targets of SARS-CoV-2 infection like viral receptor human angiotensin-converting enzyme 2 (hACE-2) and RNA dependent RNA polymerase (RdRp). We anticipate that our approach for identification of multi-target-directed ligand will provide new avenues for drug discovery against SARS-CoV-2 infection. ARTICLE HISTORY

Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus

“…The fusion of coronavirus requires proteolytic priming of its spike protein in the endosomal system. Besides, inhibition of lysosomal proteases had been hypothesised to prevent coronavirus fusion as shown in a study using mouse hepatitis virus (MHV) a safe model of coronavirus (de Haan et al, 2004;Hasan et al, 2020;Joshi et al, 2020). Various studies had been reported using computational approaches in investigating putative compounds that could be repurposed or repositioned as drugs against coronavirus (Aanouz et al, 2020;Elfiky & Azzam, 2020;Enayatkhani et al, 2020;Enmozhi et al, 2020;Gupta et al, 2020;Khan et al, 2020b;Sarma et al, 2020).…”

Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target

“…The main active ingredient of turmeric, Curcumin has been widely studied to have a broad spectrum of medicinal value ranging from anti-cancerous, anti-inflammatory and an anti-amyloidogenic activity (Bhagya & Raveendra, 2017). Several computational studies related to drug or vaccine development against SARS-CoV-2 is recently published (Aanouz et al, 2020;Gupta et al, 2020;Joshi et al, 2020;Muralidharan et al, 2020;Sarma et al, 2020).…”

Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2

“…SARS-CoV-2 also called 'severe acute respiratory syndrome coronavirus 2' abbreviated SARS-CoV-2 was recognized to be the causative of atypical pneumonia (Joshi, 2020;Pant et al, 2020) outbreak in Wuhan, China (Hasan, 2020;S. A. Khan et al, 2020).…”